Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.
The authors examined the relation between time since onset of illicit drug injection (time at risk) and rates of hepatitis C virus (HCV) infection by using meta-regression. In 72 prevalence studies, median time since onset of injection was 7.24 years and median prevalence was 66.02%. The model showed statistically significant linear and quadratic effects of time at risk on HCV prevalence and significantly higher prevalence in developing and transitional countries and in earlier samples (1985-1995). In developed countries post-1995, mean fitted prevalence was 32.02% (95% confidence interval: 25.31, 39.58) at 1 year of injection and 53.01% (95% confidence interval: 40.69, 65.09) at 5 years. In developing/transitional countries post-1995, mean fitted HCV prevalence was 59.13% (95% confidence interval: 30.39, 82.74) at 1 year of injection. In 10 incidence studies, median time at risk was 5.29 years and median cumulative HCV incidence was 20.69%. Mean fitted cumulative incidence was 27.63% (95% confidence interval: 16.92, 41.70) at 1 year of drug injection. The authors concluded that time to HCV infection in developed countries has lengthened. More rapid onset of HCV infection in drug injectors in developing/transitional countries resembles an earlier era of the HCV epidemic in other regions.
Center for Drug Use and HIV Research, National Development and Research Institutes (NDRI), 71 West 23rd Street, New York, NY 10010, USA. hagan@ndri.org
Holly
H
Hagan
Enrique R
ER
Pouget
Don C
DC
Des Jarlais
Corina
C
Lelutiu-Weinberger
D016001:Confidence Intervals; D005260:Female; D006526:Hepatitis C / Q000209:etiology*; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D015995:Prevalence; D015819:Substance Abuse, Intravenous / Q000150:complications*; D013997:Time Factors